{
 "PrintNo":"A3575","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2021-01-27T15:57:32.646341Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Higher Education",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Higher Education"}],
 "Actions":[
  {"Text":"REFERRED TO HIGHER EDUCATION","Date":"2021-01-27","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HIGHER EDUCATION","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":498,"Name":"Steven Cymbrowitz","Short":"CYMBROWITZ"}],
 "Title":"Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product",
 "Summary":"Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product; oral and written notification.",
 "LawSection":"Education Law","LawCode":"Amd ยง6810, Ed L",
 "ActClause":"AN ACT to amend the education law, in relation to notification of the substitution of one generic drug product for another generic drug",
 "PreviousVersions":["A4605-2015","A3669-2017","A5143-2019"]
}